Assessment of selected angiogenesis markers in the serum of middle‐aged male patients with plaque psoriasis
- 30 December 2020
- journal article
- research article
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 34 (1), e14727
- https://doi.org/10.1111/dth.14727
Abstract
Local angiogenesis accompanies inflammation in psoriasis‐affected skin. To determine the serum concentrations of selected pro‐ and anti‐angiogenic factors and their interrelationships in patients with plaque psoriasis. The study included 41 men diagnosed with psoriasis, aged 43.5 ± 11.7 years. The Psoriasis Area and Severity Index score was 23.4 ± 5.2 points. The control group consisted of 38 healthy, age‐matched men. The levels of pro‐angiogenic cytokines and angiogenesis inhibitors, including fibroblast growth factor 1 (FGF‐1), vascular endothelial growth factor A (VEGF‐A), endostatin, and angiostatin, were determined from the serum of patients and controls using enzyme‐linked immunosorbent assays. Compared with controls, patients with psoriasis had a significantly lower concentration of FGF‐1 (P = .01) but higher concentrations of endostatin (P = .04) and angiostatin (P = .02). The concentration of VEGF‐A was also higher in patients with psoriasis but not significantly (P = .25). The concentration of C‐reactive protein (CRP) was significantly higher among patients with psoriasis than controls (P < .0001). Among controls, CRP concentrations did not correlate significantly with the concentrations of FGF‐1, VEGF‐A, endostatin, or angiostatin. Among patients with psoriasis, CRP concentrations correlated moderately with the concentrations of VEGF‐A (r = .35; P = .02) and angiostatin (r = .31; P = .04). The concentration of VEGF‐A correlated positively with PASI (r = .05; P = .0009) and BSA values (r = .39; P = .01). Psoriasis is associated with an altered systemic balance between pro‐angiogenic and anti‐angiogenic factors. The increase in serum angiogenesis inhibitors may be associated with unfavorable changes in the development of coronary collateral circulation. However, the clinical significance of this has not yet been established.Keywords
Funding Information
- Uniwersytet Medyczny w Lublinie (DS 168)
This publication has 30 references indexed in Scilit:
- Effect of psoriasis activity on VEGF and its soluble receptors concentrations in serum and plaque scalesCytokine, 2010
- Serum Levels of Vascular Endothelial Growth Factor and Basic Fibroblastic Growth Factor in Children with Hemangiomas and Vascular Malformations—Preliminary ReportPediatric Dermatology, 2009
- Angiogenesis drives psoriasis pathogenesisInternational Journal of Experimental Pathology, 2009
- Endostatin and angiostatin are increased in diabetic patients with coronary artery disease and associated with impaired coronary collateral formationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Discrepant levels of vascular endothelial growth factor in psoriasis patients treated with PUVA, Re-PUVA and narrow-band UVBPhotodermatology, Photoimmunology & Photomedicine, 2008
- Circulating cytokines in Norwegian patients with psoriatic arthritis determined by a multiplex cytokine array systemRheumatology, 2007
- Vascular endothelial growth factor gene polymorphisms increase the risk to develop psoriasisExperimental Dermatology, 2006
- Cytokine profiles during infliximab monotherapy in psoriatic arthritisBritish Journal of Dermatology, 2005
- Physiological role of collagen XVIII and endostatinThe FASEB Journal, 2005
- Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasisBritish Journal of Dermatology, 1999